Article
ARID1A Upregulation Predicts Poor Survival in Patients With Liver Cancer
2021-01-19
Abstract excerpt
<h4>Objective: </h4> ARID1A has been identified as a possible biomarker for certain cancers. There is, however, some debate regarding its function in liver cancer. <h4>Methods: </h4>: Associations between clinical variables and ARID1A were evaluated. Cox and Kaplan – Meier analysis were used to examine clinical pathological factors linked to overall survival of patients with liver cancer. Gene set enrichment analy...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3519006b-bda8-5ad1-920f-caa9fb99da90
- DOI
- 10.21203/rs.3.rs-146505/v1
